iOR Partners

iOR Partners

Medical Practices

Kansas City, MO 2,279 followers

We provide a turnkey solution for office-based surgery in ophthalmology: planning, development, operations and support.

About us

iOR Partners are pioneers of office-based cataract surgery (OBS) in ophthalmology. We work with leading ophthalmologists to transform their practices into OBS suites. iOR OBS suites are unique and separate from the traditional ASC, providing surgeons the ability to offer more personalized care in a safe and comfortable surgical environment. We provide each client with the time and guidance they deserve to develop a customized, comprehensive and ongoing office-based surgery program that adheres to the highest clinical and ethical standards. Our proprietary solution is turnkey and comes with a range of services including financial support for space build-out, capital equipment acquisition, staff training, administration, product supply and support services from concept to accreditation. Advantages of iOR Office-Based Surgery Suites - Seamlessly integrates clinic and surgery within the surgeon’s office - Utilizes highest level of patient safety - Provides a familiar and personalized premium surgical experience - Patient-friendly surgical facility reduces patient anxiety associated with ASC - Surgical staff works for the Surgeon - Combines clinic and surgery schedules - Increases patient capacity - Retains surgical revenues within the practice - Additional insurance reimbursements that traditionally would be paid to ASC iOR Partners is the only company dedicated to OBS suites and has established more than 100 office-based suites nationwide. With 100+ combined years of experience, our clients enjoy peace of mind when transforming their office and practice into an iOR office-based surgery suite.

Industry
Medical Practices
Company size
11-50 employees
Headquarters
Kansas City, MO
Type
Privately Held

Locations

Employees at iOR Partners

Updates

Similar pages

Browse jobs

Funding

iOR Partners 1 total round

Last Round

Series unknown

US$ 9.2M

See more info on crunchbase